343 related articles for article (PubMed ID: 31909152)
1. Comorbidities of hidradenitis suppurativa: A review of the literature.
Cartron A; Driscoll MS
Int J Womens Dermatol; 2019 Dec; 5(5):330-334. PubMed ID: 31909152
[TBL] [Abstract][Full Text] [Related]
2. Hidradenitis Suppurativa at an Uncommon Site: A Review of Its Clinical Features, Diagnostic Difficulties, and Management.
Harvey LM; Fortson JK
Cureus; 2021 Oct; 13(10):e18704. PubMed ID: 34790460
[TBL] [Abstract][Full Text] [Related]
3. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
4. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.
Nguyen TV; Damiani G; Orenstein LAV; Hamzavi I; Jemec GB
J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):50-61. PubMed ID: 32460374
[TBL] [Abstract][Full Text] [Related]
5. What is hidradenitis suppurativa?
Lee EY; Alhusayen R; Lansang P; Shear N; Yeung J
Can Fam Physician; 2017 Feb; 63(2):114-120. PubMed ID: 28209676
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.
Napolitano M; Megna M; Timoshchuk EA; Patruno C; Balato N; Fabbrocini G; Monfrecola G
Clin Cosmet Investig Dermatol; 2017; 10():105-115. PubMed ID: 28458570
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial effects of hidradenitis suppurativa in the literature: A systematic review.
Richards E; Joshi A
Int J Psychiatry Med; 2024 Apr; ():912174241249215. PubMed ID: 38644350
[TBL] [Abstract][Full Text] [Related]
8. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
Garg A; Malviya N; Strunk A; Wright S; Alavi A; Alhusayen R; Alikhan A; Daveluy SD; Delorme I; Goldfarb N; Gulliver W; Hamzavi I; Jaleel T; Kimball AB; Kirby JS; Kirchhof MG; Lester J; Lev-Tov H; Lowes MA; Micheletti R; Orenstein LA; Piguet V; Sayed C; Tan J; Naik HB
J Am Acad Dermatol; 2022 May; 86(5):1092-1101. PubMed ID: 33493574
[TBL] [Abstract][Full Text] [Related]
9. Practical Guidelines for Managing Patients With Hidradenitis Suppurativa: An Update.
Johnston LA; Alhusayen R; Bourcier M; Delorme I; George R; O'Brien E; Wong SM; Poelman SM
J Cutan Med Surg; 2022; 26(2_suppl):2S-24S. PubMed ID: 36000460
[TBL] [Abstract][Full Text] [Related]
10. Psychiatric comorbidities in patients with hidradenitis suppurativa.
Misitzis A; Goldust M; Jafferany M; Lotti T
Dermatol Ther; 2020 Jul; 33(4):e13541. PubMed ID: 32385861
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa; classification, remedies, etiology, and comorbidities; a narrative review.
Mohammadi S; Gholami A; Hejrati L; Rohani M; Rafiei-Sefiddashti R; Hejrati A
J Family Med Prim Care; 2021 Nov; 10(11):4009-4016. PubMed ID: 35136760
[TBL] [Abstract][Full Text] [Related]
12. The Pathogenesis and Treatment of Hidradenitis Suppurativa.
Agnese ER; Tariche N; Sharma A; Gulati R
Cureus; 2023 Nov; 15(11):e49390. PubMed ID: 38146560
[TBL] [Abstract][Full Text] [Related]
13. Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review.
Scuderi N; Monfrecola A; Dessy LA; Fabbrocini G; Megna M; Monfrecola G
Skin Appendage Disord; 2017 May; 3(2):95-110. PubMed ID: 28560220
[TBL] [Abstract][Full Text] [Related]
14. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
Shlyankevich J; Chen AJ; Kim GE; Kimball AB
J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic Implications in Patients Suffering from Hidradenitis Suppurativa under Systemic Treatments.
Li Pomi F; Macca L; Motolese A; Ingrasciotta Y; Berretta M; Guarneri C
Biomedicines; 2021 Nov; 9(11):. PubMed ID: 34829823
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for the management of comorbidity in hidradenitis suppurativa.
Dauden E; Lazaro P; Aguilar MD; Blasco AJ; Suarez C; Marin I; Queiro R; Bassas-Vila J; Martorell A; García-Campayo J
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):129-144. PubMed ID: 28796920
[TBL] [Abstract][Full Text] [Related]
17. Insights into hidradenitis suppurativa.
van Straalen KR; Prens EP; Gudjonsson JE
J Allergy Clin Immunol; 2022 Apr; 149(4):1150-1161. PubMed ID: 35189127
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of hidradenitis suppurativa.
Bukvić Mokos Z; Markota Čagalj A; Marinović B
Clin Dermatol; 2023; 41(5):564-575. PubMed ID: 37696341
[TBL] [Abstract][Full Text] [Related]
19. Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations.
Preda-Naumescu A; Ahmed HN; Mayo TT; Yusuf N
Int J Dermatol; 2021 Nov; 60(11):e449-e458. PubMed ID: 33890304
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1.
Vekic DA; Frew J; Cains GD
Australas J Dermatol; 2018 Nov; 59(4):267-277. PubMed ID: 29355905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
